Your Article Summary
Prix Galien Awards:Best Biotechnology Product-Amgen
PharmExec, 10/12/09
Prix Galien USA recognizes outstanding efforts to improve the human condition by means of innovative biomedical research. By targeting the specific cancer–causing molecules in the body, GLEEVEC attacks cancerous cells while sparing healthy cells and the immune system.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Expanding The Biopharmaceutical Industry's Involvement In Fighting Neglected Diseases
Health Affairs, 11/19/09
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
A look at how far hospitals have come since To Err is Human report
American Hospital Association News, 11/25/09
AstraZeneca and the Philadelphia Department of Public Health provide free medicines to Pennsylvanias uninsured
AstraZeneca, 11/24/09
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Amgen, 11/24/09
Article Search
Sponsor


See Latest Articles


